Avenue Therapeutics, Inc. (ATXI): Price and Financial Metrics
Avenue Therapeutics, Inc. (ATXI)
Today's Latest Price: $10.92 USD
Updated Sep 25 4:00pm
Add ATXI to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 233 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
ATXI Stock Price Chart Technical Analysis Charts
ATXI Price/Volume Stats
| Current price | $10.92 | 52-week high | $12.34 |
| Prev. close | $10.91 | 52-week low | $4.96 |
| Day low | $10.80 | Volume | 37,691 |
| Day high | $11.16 | Avg. volume | 56,045 |
| 50-day MA | $11.00 | Dividend yield | N/A |
| 200-day MA | $9.77 | Market Cap | 182.40M |
Avenue Therapeutics, Inc. (ATXI) Company Bio
Avenue Therapeutics, Inc., a specialty pharmaceutical company, acquires, licenses, develops, and commercializes an intravenous formulation of tramadol HCI principally for use in the acute/intensive care hospital setting. Its product candidate is IV Tramadol for the treatment of post-operative pain. The company was founded in 2015 and is based in New York, New York.
Loading social stream, please wait...